What you should know:
1. Cesca issued one share for every 10 outstanding shares absorbed.
2. The company will not change how many shares it’s authorized to issue.
3. Cesca authorized the reverse split to regain compliance with the Nasdaq’s $1 minimum bid price requirement.
4. Reverse stock splits typically help companies raise the price of their shares.
5. Cesca Therapeutics creates stem cell processing technologies and autologous cell-based therapies.
More articles on devices:
Zavation receives FDA approval for new spinal fusion device — 3 insights
Indiana device company receives FDA clearance for elbow system — 3 insights
Smith & Nephew acquires orthopedic joint reconstruction business — 4 insights
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
